Several studies have proven that INPP4B expression was inhibited in digestive cancers, acute myeloid leukemia, melanomas, and breast cancer due to the deletion of the INPP4B chromosome region (9), and served as an oncogenic factor (10–13). This evidence concerns the gene INPP4B and breast cancer.